This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schumacher, F. R. Articles by Hunter, D. J. Search for Related Content PubMed PubMed Citation Articles by Schumacher, F. R. Articles by Hunter, D. J. Related Collections Related Article

A Common 8q24 Variant in Prostate and Breast Cancer from a Large Nested Case-Control Study

Departments of ¹ Epidemiology and ² Nutrition, ³ Program in Molecular and Genetic Epidemiology, Harvard School of Public Health; Divisions of ⁴ Preventive Medicine and ⁵ Aging, ⁶ Channing Laboratory, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School; ⁷ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; ⁸ Department of Epidemiology and Surveillance Research, American Cancer Society, National Home Office, Atlanta, Georgia; ⁹ Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; ¹⁰ Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; ¹¹ Core Genotyping Facility, National Cancer Institute, Gaithersburg, Maryland; ¹² Department of Oncology, University of Cambridge, Cambridge, United Kingdom; ¹³ Hormones and Cancer Group, ¹⁴ Unit of Nutrition and Cancer, International Agency for Research on Cancer, Lyon, France; ¹⁵ Epidemiology Unit, Cancer Research United Kingdom, University of Oxford, Oxford, United Kingdom; ¹⁶ Cancer Research Center, University of Hawaii, Honolulu, Hawaii; ¹⁷ Fondation Jean Dausset, Centre d'Etude du Polymorphisme Humain, Paris, France; ¹⁸ Cancer Prevention Unit, National Public Health Institute, Helsinki, Finland; ¹⁹ Division of Urology, Washington University School of Medicine, St. Louis, Missouri; and ²⁰ Division of Hematology and Oncology, Milstein Hospital, College of Physicians and Surgeons, Columbia University, New York, New York

Requests for reprints: David J. Hunter, Channing Laboratory, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115. Phone: 617-525-2755; E-mail: dhunter{at}hsph.harvard.edu.

Two recent studies independently identified polymorphisms in the 8q24 region, including a single nucleotide polymorphism (rs1447295), strongly associated with prostate cancer risk. Here, we replicate the overall association in a large nested case-control study from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium using 6,637 prostate cancer cases and 7,361 matched controls. We also examine whether this polymorphism is associated with breast cancer among 2,604 Caucasian breast cancer cases and 3,118 matched controls. The rs1447295 marker was strongly associated with prostate cancer among Caucasians (P = 1.23 x 10^–13). When we exclude the Multiethnic Cohort samples, previously reported by Freedman et al., the association remains highly significant (P = 8.64 x 10^–13). Compared with wild-type homozygotes, carriers with one copy of the minor allele had an OR_AC = 1.34 (99% confidence intervals, 1.19–1.50) and carriers with two copies of the minor allele had an OR_AA = 1.86 (99% confidence intervals, 1.30–2.67). Among African Americans, the genotype association was statistically significant in men diagnosed with prostate cancer at an early age (P = 0.011) and nonsignificant for those diagnosed at a later age (P = 0.924). This difference in risk by age at diagnosis was not present among Caucasians. We found no statistically significant difference in risk when tumors were classified by Gleason score, stage, or mortality. We found no association between rs1447295 and breast cancer risk (P = 0.590). Although the gene responsible has yet to be identified, the validation of this marker in this large sample of prostate cancer cases leaves little room for the possibility of a false-positive result. [Cancer Res 2007;67(7):2951–6]

Related Article

Genetic Variation at 8q24 as a Susceptibility Factor for Prostate Cancer: Definitive Results from Epidemiologic Studies?

Elizabeth A. Platz
Cancer Res. 2007 67: 2905-2907. [Full Text] [PDF]

This article has been cited by other articles:

				C. A. Salinas, E. Kwon, C. S. Carlson, J. S. Koopmeiners, Z. Feng, D. M. Karyadi, E. A. Ostrander, and J. L. Stanford Multiple Independent Genetic Variants in the 8q24 Region Are Associated with Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1203 - 1213. [Abstract] [Full Text] [PDF]

				O. Fletcher, N. Johnson, L. Gibson, B. Coupland, A. Fraser, A. Leonard, I. dos Santos Silva, A. Ashworth, R. Houlston, and J. Peto Association of Genetic Variants at 8q24 with Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 702 - 705. [Abstract] [Full Text] [PDF]

				S. L. Zheng, J. Sun, F. Wiklund, S. Smith, P. Stattin, G. Li, H.-O. Adami, F.-C. Hsu, Y. Zhu, K. Balter, et al. Cumulative Association of Five Genetic Variants with Prostate Cancer N. Engl. J. Med., February 28, 2008; 358(9): 910 - 919. [Abstract] [Full Text] [PDF]

				L. Li, S. J. Plummer, C. L. Thompson, A. Merkulova, L. S. Acheson, T. C. Tucker, and G. Casey A Common 8q24 Variant and the Risk of Colon Cancer: A Population-Based Case-Control Study Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 339 - 342. [Abstract] [Full Text] [PDF]

				S. Tuupanen, I. Niittymaki, K. Nousiainen, S. Vanharanta, J.-P. Mecklin, K. Nuorva, H. Jarvinen, S. Hautaniemi, A. Karhu, and L. A. Aaltonen Allelic Imbalance at rs6983267 Suggests Selection of the Risk Allele in Somatic Colorectal Tumor Evolution Cancer Res., January 1, 2008; 68(1): 14 - 17. [Abstract] [Full Text] [PDF]

				C. Robbins, J. B. Torres, S. Hooker, C. Bonilla, W. Hernandez, A. Candreva, C. Ahaghotu, R. Kittles, and J. Carpten Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus Genome Res., December 1, 2007; 17(12): 1717 - 1722. [Abstract] [Full Text] [PDF]

				S. A. Savage and M. H. Greene The Evidence for Prostate Cancer Risk Loci at 8q24 Grows Stronger J Natl Cancer Inst, October 17, 2007; 99(20): 1499 - 1501. [Full Text] [PDF]

				E. A. Platz Genetic Variation at 8q24 as a Susceptibility Factor for Prostate Cancer: Definitive Results from Epidemiologic Studies? Cancer Res., April 1, 2007; 67(7): 2905 - 2907. [Full Text] [PDF]